Astermark J - Search Results

1

Anti-factor VIII antibodies in brothers with haemophilia A share similar characteristics.

Kahle J, Orlowski A, Stichel D, Healey JF, Parker ET, Donfield SM, Astermark J, Berntorp E, Lollar P, Schwabe D, Königs C. Kahle J, et al. Among authors: astermark j. Haemophilia. 2017 Mar;23(2):292-299. doi: 10.1111/hae.13105. Epub 2016 Nov 8. Haemophilia. 2017. PMID: 27862687

2

[Antithrombin III concentrate seeks its therapeutic role. Be careful and wait for the results of the studies!].

Astermark J, Lethagen S, Berntorp E. Astermark J, et al. Lakartidningen. 1996 Oct 23;93(43):3773-6, 3778. Lakartidningen. 1996. PMID: 8965549 Review. Swedish. No abstract available.

3

No effect of a new second-generation B-domain-deleted recombinant product on lymphocyte transformation in vitro: a study of plasma-derived and recombinant products.

Astermark J, Ekman M, Berntorp E. Astermark J, et al. Br J Haematol. 1997 Nov;99(2):289-94. doi: 10.1046/j.1365-2141.1997.4153222.x. Br J Haematol. 1997. PMID: 9375741 Free article.

4

[Hemophiliacs with HIV. Slower progression of the infection among younger patients and at higher dosages of factor concentrates].

Astermark J, Berntorp E, Stigendal L, Johnsson H. Astermark J, et al. Lakartidningen. 1998 Jan 7;95(1-2):48-50. Lakartidningen. 1998. PMID: 9458646 Swedish.

5

Low recurrence rate after deep calf-vein thrombosis with 6 weeks of oral anticoagulation.

Astermark J, Björgell O, Lindén E, Lethagen S, Nilsson P, Berntorp E. Astermark J, et al. J Intern Med. 1998 Jul;244(1):79-82. doi: 10.1046/j.1365-2796.1998.00318.x. J Intern Med. 1998. PMID: 9698028 Free article.

6

Major surgery seems not to influence HIV disease progression in haemophilia patients.

Astermark J, Löfqvist T, Schulman S, Stigendal L, Lethagen S, Nilsson IM, Berntorp E. Astermark J, et al. Br J Haematol. 1998 Oct;103(1):10-4. doi: 10.1046/j.1365-2141.1998.00961.x. Br J Haematol. 1998. PMID: 9792282 Free article. Clinical Trial.

7

The Malmö-Klaipeda WFH twinning programme: a comparative description of the haemophilia cohorts.

Berntorp E, Astermark J, Jurgutis R, Lethagen S, Petersson C. Berntorp E, et al. Among authors: astermark j. Haemophilia. 1998 Mar;4(2):79-82. doi: 10.1046/j.1365-2516.1998.00169.x. Haemophilia. 1998. PMID: 9873842 Clinical Trial.

8

Malmö International Brother Study (MIBS): an international survey of brother pairs with haemophilia.

Astermark J, Berntorp E. Astermark J, et al. Vox Sang. 1999;77 Suppl 1:80-2. doi: 10.1159/000056723. Vox Sang. 1999. PMID: 10529695

9

Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized.

Astermark J, Petrini P, Tengborn L, Schulman S, Ljung R, Berntorp E. Astermark J, et al. Br J Haematol. 1999 Jun;105(4):1109-13. doi: 10.1046/j.1365-2141.1999.01463.x. Br J Haematol. 1999. PMID: 10554828 Free article.

10

Correlation between different intensities of anti-vitamin K treatment and coagulation parameters.

Jerkeman A, Astermark J, Hedner U, Lethagen S, Olsson CG, Berntorp E. Jerkeman A, et al. Among authors: astermark j. Thromb Res. 2000 Jun 15;98(6):467-71. doi: 10.1016/s0049-3848(00)00203-6. Thromb Res. 2000. PMID: 10899345

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

188 results

Search Page

Filters